Ultragenyx Pharmaceutical (RARE) Non-cash Items (2013 - 2017)

Ultragenyx Pharmaceutical (RARE) has 5 years of Non-cash Items data on file, last reported at $2.7 million in Q4 2017.

• Quarterly Non-cash Items fell 96.58% year-over-year to $2.7 million in Q4 2017, while the trailing twelve-month figure through Dec 2017 was $2.7 million (down 96.58% YoY) and the FY2017 annual result came in at $2.7 million, up 67.21% from the prior year.
• Non-cash Items slipped to $2.7 million in Q4 2017 per RARE's latest filing, from $79.1 million in the prior quarter.
• Across five years, Non-cash Items topped out at $217.4 million in Q4 2015 and bottomed at $2.7 million in Q4 2017.
• The 5-year median for Non-cash Items is $79.1 million (2016), against an average of $79.7 million.
• The widest annual swing landed in 2014, when Non-cash Items surged 310.11%; it then slumped 96.58% in 2017.
• Tracing RARE's Non-cash Items over 5 years: stood at $19.5 million in 2013, then jumped by 310.11% to $79.8 million in 2014, then soared by 172.28% to $217.4 million in 2015, then tumbled by 63.6% to $79.1 million in 2016, then tumbled by 96.58% to $2.7 million in 2017.
• Per Business Quant, the three latest RARE Non-cash Items figures stand at $2.7 million (Q4 2017), $79.1 million (Q4 2016), and $217.4 million (Q4 2015).

Peer Comparison